Guest Editor: Pellegrino Musto HOW FIRST-LINE THERAPY IS CHANGING IN NON-TRANSPLANT ELIGIBLE MULTIPLE MYELOMA PATIENTS. (2025). Mediterranean Journal of Hematology and Infectious Diseases, 17(1), e2025025. https://doi.org/10.4084/MJHID.2025.025